Title of article
Clinical correlates of the initial and long-term cost of coronary bypass surgery and coronary angioplasty
Author/Authors
Mark A. Hlatky، نويسنده , , Derek B. Boothroyd، نويسنده , , Maria Mori Brooks، نويسنده , , Carla Winston، نويسنده , , Allan Rosen، نويسنده , , William J. Rogers، نويسنده , , Guy S. Reeder، نويسنده , , Hugh C. Smith، نويسنده , , Thomas J. Ryan، نويسنده , , Bertram Pitt، نويسنده , , Patrick L. Whitlow، نويسنده , , Robert D. Wiens، نويسنده , , Daniel B. Mark، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 1999
Pages
8
From page
376
To page
383
Abstract
Background Medical costs vary substantially among patients. Understanding the baseline factors that predict subsequent cost may allow better selection of therapy for individual patients. Understanding the postprocedure events that increase cost should help to improve efficiency and effectiveness of coronary revascularization. Methods Data on 4-year costs were collected from patients randomly assigned to coronary angioplasty or bypass surgery as part of the BARI (Bypass Angioplasty Revascularization Investigation) trial. Regression models first examined factors known at the time of randomization that prospectively predicted initial procedure cost and long-term cost. Subsequent models tested the value of postrandomization events as explanatory variables for cost. Results The independent baseline predictors of higher initial percutaneous transluminal coronary angioplasty cost included 3-vessel disease (+12%) and acute presentations (+22%), whereas the independent predictors of higher initial coronary artery bypass grafting cost included the number of comorbid conditions (+5% per condition) and female sex (+7%). The independent baseline predictors of 4-year cost included heart failure (+26%), diabetes (+22%), comorbidity (+10%), and angioplasty assignment in patients with 2-vessel disease (–15%). Postrandomization models showed higher initial and long-term costs were strongly correlated with the number of repeat revascularization procedures (+30% to +128%) and the occurrence of clinical complications (+8% to +131%). Conclusions Two-vessel disease identifies patients likely to have lower costs after angioplasty, whereas heart failure, comorbid conditions, and diabetes identify patients likely to accrue higher costs after either angioplasty or bypass surgery. Long-term costs can be potentially reduced by interventions that decrease procedural complications or reduce the need for repeat revascularization. (Am Heart J 1999;138:376-83.)
Journal title
American Heart Journal
Serial Year
1999
Journal title
American Heart Journal
Record number
531727
Link To Document